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The Value of Ultrasonography and
Tumor Markers in the Differential Diagnosis of
Postmenopausal Ovarian Cysts
Aim: To evaluate the use of tumor markers in the differentiation of malignant and benign ovarian cysts in the
postmenopausal period.
Materials and Methods: The study included postmenopausal 46 patients with ovarian cysts that were
assessed pre- and postoperatively using CA125 levels, ultrasonographic findings, and histopathological
examination at the Obstetrics and Gynecology Clinic, Ankara Atatürk Training and Research Hospital.
Results: Mean age of menopause onset was 46 years and mean duration of menopause was 11 years.
Histopathological examination revealed that 28.3% of the ovarian cysts were malignant and 71.7% were
benign. Of the malignant cysts, 84% were unilateral, with a mean diameter of 74.61 mm; mean diameter of
the benign cysts was 58 mm. While 80% of cysts with a high CA125 value were malignant, 20% were benign.
Pathological examination revealed that 96.8% of cysts with a normal CA125 value were benign and 3.2%
were malignant. Mean CA125 values were 264 U/ml for malignant cysts and 14.2 U/ml for benign cysts. When
pathological assessment was based only on ultrasonographic findings, 73.9% of the ovarian cysts were
malignant and 26.1% were benign. While unilateral or bilateral localization in the ultrasonography was
insignificant, the presence of a solid component was a good predictor of malignancy (P = 0.0001).
Conclusions: In the differentiation of benign and malignant cysts in postmenopausal women, the presence of
a solid component based on ultrasonography, cysts larger than 5-6 cm, and high CA125 values may be used
as discriminative criteria. For those patients with cysts that are assumed to be benign follow-up may be an
option for reducing the mortality and morbidity associated with surgery.
Key Words: Postmenopause, ovarian cysts, tumor markers, ultrasonography

Postmenopozal Over Kistlerinin Ayırıcı Tanısında Ultrasonografi ve Tümör
Belirteçlerinin Değeri
Amaç: Postmenopozal dönemde görülen over kistlerinin malign – benign ayrımı yapmak için tümör
belirteçlerinin değerlendirilmesi.
Yöntem ve Gereç: Ankara Atatürk Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniğinde
postmenopozal dönemde tespit edilen 46 over kisti olgusunun pre ve post operatif olarak değerlendirmelerinin
CA125 ölçümü, ultrasonografi bulguları ve patolojik inceleme sonuçları ile yapılması.
Bulgular: Ortalama menopoz yaşı 46, ortalama menopoz yılı 11 olarak bulundu. Over kistlerinin % 28,3’ ü
malign, % 71,7’ si benign olarak patolojik tetkikleri rapor edildi.
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Malign olanların % 84’ü unilateral olup ortalama çapları 74,61 mm, benign olanların ise ortalama çapları 58
mm olarak ölçüldü. CA125 değeri yüksek olanların % 80’ i malign % 20’si benign idi. CA125 değeri normal
olanların % 96,8’i benign, % 3,2’si malign olarak patolojik tanıları konuldu.Malign olanların ortalama CA125
değeri 264 U/ml, benign olanların 14,2 U/ml bulundu. Yalnızca ultrasonografi sonuçlarına göre patolojiler
değerlendirildiğinde % 73,9’u malign, % 26,1’i benign çıktı. Ultrasonografide uni ya da bilateral yerleşiminin
önemli olmadığı, solid komponentin malignitede iyi bir gösterge olabileceği tespit edildi (P = 0,0001).

Mustafa UZUN
Department of Obstetrics and
Gynecology,
Ankara Atatürk Training and
Research Hospital,
Ankara - TURKEY
drmustafauzun@hotmail.com

Sonuç: Postmenopozal kistlerin takibinde benign – malign ayrımının yapılmasında ultrasonografide solid
komponent varlığı, kistin boyutunun 5-6 cm den büyük olması ve CA125 değerinin yüksek olması kriter olarak
kullanılabilir. Benign düşünülen hastalarda operatif morbidite ve mortaliteyi azaltmak için bekleme tedavisi
yapılabilir.
Anahtar Sözcükler: Postmenopoz, over kisti, tanı, tümör belirteci, ultrasonografi
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Introduction
Mortality due to ovarian cancer remains high, with a
5-year survival rate of 50%, despite considerable
healthcare developments in recent years (1). Over 70%
of ovarian cancers are diagnosed at stage 3-4 (2). The
incidence is 0.4-8.9/100,000 among women younger
than 40 years, whereas it increases up to 60/100,000
among those aged between 60 and 80 years (3).
While palpable adnexal masses or ovaries in
postmenopausal women were previously considered
indications for surgery, widespread use of
ultrasonographic examination and supplementation with
laboratory tests provided the opportunity to only follow
up patients with a low risk of malignancy (4). Yet,
surgical interventions for early diagnosis of ovarian
cancer increase the risk of morbidity and mortality, and
may affect decisions concerning surgery.
The aim of the present study was to assess
postmenopausal women with cysts using preoperative
tumor markers and ultrasonography (USG) to
preliminarily differentiate benign and malignant cysts,
and to compare this assessment with postoperative
results.
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with the McNemar test. P values less than 0.05 with a
95% confidence interval were considered significant.

Results
Mean age of the patients was 46 ± 8.4 years and
mean duration of menopause was 11.1 ± 8.6 years.
Mean age of patients with benign and malignant
pathology was 61 and 59 years, respectively; the
difference was not statistically significant. According to
histopathological examination, the prevalence of
malignancy was 28.3% and the prevalence of benign
cysts was 71.7%. The frequency of unilateral cysts was
84% in patients with malignant pathology and 94% in
those with benign masses; the difference was not
significant. While the maximum cyst diameter and mean
diameter of malignant tumors was 90.61 mm and 74
mm, respectively, the corresponding figures for benign
masses were 63.54 mm and 58 mm, respectively.

Materials and Methods

Among the patients with a high CA125 value (normal
values 0-35), 80% of ovarian cysts were malignant and
20% were benign; the corresponding percentages for
patients with normal CA125 levels were 96.8% and
3.2%, respectively. There was a significant correlation
between CA125 values and pathological findings (P =
0.0001, Fisher’s exact test).

The study group included 46 postmenopausal women
with adnexal masses that presented to the Obstetrics and
Gynecology Clinic, Ankara Atatürk Training and Research
Hospital between February 2004 and May 2007. Patients
with a previous diagnosis of malignancy were excluded.

Overall, 28.3% of the patients had high CA125 levels
and malignant histopathological results, 67.4% had
normal CA125 levels and benign histopathological results,
and 4.3% had either normal CA125 levels and malignant
cysts or high CA125 values and benign cysts.

Age, menopausal duration, symptoms, laboratory
findings, transvaginal ultrasonography (TVUSG) findings,
tumor markers (CA125), and postoperative
histopathology findings of each patient were recorded.
With TVUSG the cysts were assessed for multilocular
appearance, bilateral location, presence of septation,
papillary structure content, size, and wall structure.
Histopathological examination findings were considered
the gold standard.

Based on TVUSG findings alone, 73.9% of the cysts
were malignant and 26.1% were benign (sensitivity
92.3%, specificity 33.3%). The low specificity suggests
that 33.3% of patients with benign pathology also had
benign ultrasonographic findings (positive predictive
value = 35.3%) (negative predictive value = 91.7%). The
McNemar test indicated that TVUSG and histopathology
results correlated significantly (P = 0.0001).

SPSS was used for statistical analyses. Variables with
parametric distribution were analyzed with the t test; the
Mann-Whitney U test and the Wilcoxon test were used for
variables with nonparametric distribution. CA125 values
and histopathological examination findings were
compared using Fischer’s exact test, and ultrasonographic
and pathological examination findings were compared
180

Cysts were unilateral in 93.9% of the patients with
benign histopathological findings and in 84.6% of those
with malignant histopathological results. There was no
significant correlation between histopathological findings
and unilateral/bilateral location (P = 0.565, Fisher’s exact
test). Solid components were present in 76.9% of
patients with malignant histopathological results and in
27.3% of those with benign findings.
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Table. Comparison of ultrasonographical and histopathological findings.
PATHOLOGY
Total

Malignant

Benign

Total

Malignant

Benign

12

22

34

% within USG

35.3%

64.7%

100.0%

% within pathology

92.3%

66.7%

73.9%

1

11

12

% within USG

8.3%

91.7%

100.0%

% within pathology

7.7%

33.3%

26.1%

13

33

46

% within USG

28.3%

71.7%

100.0%

% within pathology

100.0%

100.0%

100.0%

Number

Number

Number

Histopathological distribution of benign cysts was as
follows: benign serous cyst: 66.7%; fibroma: 9.1%;
dermoid cyst: 6.1%; cystadenofibroma: 6.1%; serous
cystadenoma: 3%; mucinous cystadenoma: 9.1%. For
malignant cysts histopathological distribution was as follows:
granulosa cell tumor: 15.4%; serous cystadenocarcinoma:
61.5%; mucinous cystadenocarcinoma: 15.1%; transitional
cell carcinoma: 2.7%.
Discussion
Efforts directed at the early diagnosis of ovarian
cancer have resulted in increasing the number of surgical
interventions, which has led to a rise in mortality and
morbidity. The most widely used modalities for accurate
diagnosis are CA125 measurement and TVUSG. The
specificity and sensitivity of tumor markers alone are low
for all age groups. They are more useful for follow-up
than for diagnosis (5). CA125 is a nonspecific marker,
which may increase in acute hepatitis, acute pancreatitis,
pregnancy, cirrhosis, and systemic lupus erythematosus.
The significance of this marker alone in ovarian
pathologies in the postmenopausal period is unclear.
Tuxen et al. reported that CA125 levels were within the
normal range in 10%-20% of patients with ovarian
cancer and in about 50% of those with stage 1 lesions

(5). Thus, interpretation of CA125 levels, along with
physical findings, was suggested. In the present study
CA125 levels were high in 92.3% of malignant cases and
normal in 7.7%, which are close to the rates reported in
Tuxen’s study; however, malignancy should always be
considered in patients with a high CA125 level. CA125
levels were high in 80% of cases in a study by Kabawat
et al. (6).
TVUSG is the most effective method for showing the
presence of postmenopausal ovarian cysts. Sassone et al.
reported a morphological scoring system using
conventional ‘gray scale’ TVUSG to facilitate the
differentiation of malignant and benign tumors. The
sensitivity of the scoring system was 100%, specificity
was 83%, positive predictive value (PPV) was 37%, and
negative predictive value (NPV) was 100% (7). The
corresponding values for TVUSG in the present study
were 92.3%, 33.3%, 35.3%, and 91.7%, respectively,
and, except for sensitivity, appear to be in accordance
with those in Sassone et al.’s study. Fenchel et al.
reported that the sensitivity and specificity of TVUSG
were 92% and 60%, respectively (8). The TVUSG
parameters in the present study were size, solid
component, septation, presence of ascites, and
uni/bilateral location.
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Ovary volume decreases with age in the
postmenopausal period. Goswamy et al. examined the
volume of the ovaries in 2221 postmenopausal women
and noted that ovarian volume decreased with age by a
mean 1.5 1 0.5 cm. Only 10% of postmenopausal
women with palpable ovaries had ovarian cancer; the
remaining patients had tumors, such as fibromas or
Brenner tumors (9).
Considering TVUSG parameters separately in the
discrimination of benign and malignant ovarian cysts in
the present study, mean size of the benign ovarian cysts
was 58 mm. Of the 22 cases with cysts less than 58 mm,
only 3 were malignant (true positivity: 87.37%; false
positivity 13.63%). In all, 6 cases with cysts greater than
90.6 mm were benign and 5 cases were malignant. Of
those patients with cysts 58-90.6 mm, 8 were benign
and 5 were malignant. Although the likelihood of
malignancy increases with cyst size, size alone is not an
indication for surgery.
Of the 17 cases in the present study with septate
cysts, 6 were malignant; however, this was not a
predictor for malignancy. Solid components were present
in 19 patients, of which 10 were malignant and 9 were
benign. Overall, 10 of 13 the malignant cases had a solid
component. Solid component frequency in malignant
cases was 76.92%, which was quite high. The true and
false positivity values for the presence of a solid
component in the differentiation of malignant and benign
cysts were 76.92% and 23.08%, respectively. That is,
the presence of a solid component was the second most
significant parameter after CA125 level for an accurate
diagnosis.
The cysts were bilateral in 4 of our 46 patients; 2
were malignant and 2 were benign. Thus, bilateral
location was not a significant criterion for discrimination
between malignant and benign cysts. According to TVUSG
findings, 4 patients had solid and septated cysts greater
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than 58 mm. Similarly, there were 4 patients with cysts
greater than 90.6 mm, of which 3 were malignant and 1
was benign. Combining these parameters, false positivity
was 25% and true positivity was 75%, with high
predictivity. The only case with benign histopathology
was a mucinous cystadenoma; however, such cases may
not be considered misdiagnosed because they induce high
levels of CA125, grow rapidly, mimic malignant cysts in
TVUSG, and require surgical intervention despite their
benign pathology.
Goldenstein concluded that the incidence of
malignancy was low in postmenopausal unilocular cysts
less than 5 cm and that they could be followed with serial
TVUSG examinations, without surgical intervention (2).
Nordo et al. showed that unilocular ovarian cysts less than
50 mm did not change their benign characteristics in 226
postmenopausal women over a 5-year follow-up period,
and concluded that patients did not require surgical
intervention if the cyst did not increase in size and serum
CA125 levels were normal (10). Grab et al. compared
TVUSG with MRI and PET for the differentiation of
malignant and benign ovarian cysts, and suggested that
while they had similar specificity, TVUSG was more
sensitive. Combining the 3 techniques may increase
sensitivity and specificity; however, doing so is much
more expensive (3).
Shalev et al. treated 55 patients without complex
cysts and with normal CA125 levels with operative
laparoscopy and noted that all the cysts were benign,
whereas among 75 patients with complex cysts and high
CA125 levels that underwent laparotomy 23 had
malignant lesions (11).
In conclusion, not all cysts in postmenopausal women
require surgery; cysts less than 5 cm, particularly those
without a solid component, in patients with normal
CA125 levels may be followed up.
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